VRTX

Vertex Pharmaceuticals IncorporatedNASDAQ

519.26 USDT+0.44%Bybit perpetual · refreshed every 30s

24h value$4.7KOpen interest$28.3KFunding0.0000%vrtx.com ↗

Key filings

Earnings, material events (8-K), quarterly and annual reports, ownership reports

2026-10-208-KMaterial event report · Officer/director changeSource ↗
2026-09-018-KMaterial event report · Officer/director changeSource ↗
2026-08-0410-QQuarterly reportSource ↗
2026-08-038-KMaterial event report · Earnings releaseSource ↗
2026-07-078-KMaterial event report · Material agreement, Reg FD disclosure, Other eventsSource ↗
2026-05-14SCHEDULE 13G/A5%+ ownership (passive) (Amended)Source ↗
2026-05-14SCHEDULE 13G/A5%+ ownership (passive) (Amended)Source ↗
2026-05-138-KMaterial event report · Officer/director change, Shareholder vote resultsSource ↗
2026-05-0510-QQuarterly reportSource ↗
2026-05-048-KMaterial event report · Earnings releaseSource ↗
2026-04-30SCHEDULE 13G5%+ ownership (passive)Source ↗
2026-04-298-KMaterial event report · Officer/director changeSource ↗
2026-04-02DEF 14AProxy statementSource ↗
2026-03-318-KMaterial event report · Other eventsSource ↗
2026-03-27SCHEDULE 13G/A5%+ ownership (passive) (Amended)Source ↗

Filings are in English. Form and item labels are only a classification to help you navigate and do not interpret the filing.

Stock transactions by officers and major holders (Form 4) and notices of proposed sale (Form 144)